mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.6 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |